Clinical Trials in Ohio

Showing 11721-11740 of 17,983 trials

TERMINATEDNA32 miles

Magnetic Resonance Elastography of Cardiac Transplant Rejection

NCT02266914

Magnetic Resonance Elastography (MRE) for cardiac transplant patients.

Acute Graft Rejection

Ohio State University9 participantsStarted Jan 2014

Columbus, Ohio, United States

COMPLETEDPhase 232 miles

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

NCT02039947

This is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118436) and Trametinib (GSK1120212) combination therapy in subject with BRAF mutation-positive melanoma that has metastasized to the brain. This study will evaluate the safety and efficacy of 4 cohorts. Cohorts will consist of; V600 E, D, K, R mutations, metastases to the brain, symptomatic and asymptomatic, with or without prior local (brain) therapy, with or without prior local (brain) therapy, and range of ECOG scores from 0-2.

Melanoma and Brain Metastases

Novartis Pharmaceuticals127 participantsStarted Feb 2014

Birmingham, Alabama, United States • San Francisco, California, United States • Aurora, Colorado, United States +44 more locations

Magnetic Resonance Elastography of Cardiac Transplant Rejection

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Find Trials by Condition in Ohio

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

ST266 Versus Standard Care In Treating Partial Thickness Burns

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

The Chimerix CMX001 Registry

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes

The PROOF Study: The PICC Related Obstruction Of Flow Study

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients